Abstract
Introduction
The chemokine superfamily constitutes a group of structurally related cytokines that play pivotal roles in inflammatory and immunological responses by recruiting selective types of leukocytes (for review, see [1] [2] [3] . Currently, the family is divided into two major subfamilies based on the motif formed by the first two of the four conserved cysteine residues. One amino acid separates the two cysteine residues in the CXC subfamily whereas the two cysteines are adjacent in the CC subfamily. Furthermore, molecules potentially representing the C and CXXXC subfamilies have been reported. The CXC chemokines are further divided into two subgroups, the major one CC chemokines are highly specific for lymphocytes and their genes are mostly mapped to chromosomal sites different from the traditional gene cluster at chromosome 17q11.2 (6) (7) (8) (9) (10) (11) (12) (13) .
Previously, we have identified a novel human CC chemokine termed EBI1-ligand chemokine (ELC) (8) . EBI1, termed from Epstein-Barr virus (EBV)-induced gene 1, was an orphan seven transmembrane G-protein-coupled receptor originally isolated through its strong up-regulation in EBV-negative Burkitt's lymphoma cell lines upon infection with EBV (14) . The same receptor was independently reported with a term BLR2 from Burkitt's lymphoma receptor 2 and was shown to be induced by an EBV-encoded transactivator, EBNA-2 (15) . EBI1 was also found to be induced in CD4 ϩ T cells by infection with human T lymphotropic herpes viruses, HHV6 and HHV7 (16) . Previously, we have shown that ELC specifically binds to EBI1 with a high affinity, and induces chemotaxis and calcium mobilization in EBI1-transfected cells (8) . Thus, ELC is a high-affinity functional ligand for EBI1, now termed CCR7. ELC is constitutively expressed in various lymphoid tissues such as thymus and lymph nodes (8) . We have also mapped the ELC gene (SCYA19) to chromosome 9p13, instead of traditional chromosome 17q11.2 (5) , and close to the gene (SCYA21) encoding another lymphocyte-specific CC chemokine, secondary lymphoid-tissue chemokine (SLC) (8, 13) . Independently, the same chemokine was reported with a term MIP-3β and was shown to be induced in monocytes stimulated with lipopolysaccharide, especially in the presence of anti-IL-10 (17).
EBI1/CCR7 has been shown to be selectively expressed on some lymphoid cell lines (14, 18) . However, its expression and function in normal human lymphocytes have not been examined in detail. Here we have investigated the chemotactic activity of ELC on peripheral blood lymphocytes (PBL). ELC induced migration selectively in lymphocytes, i.e. both CD4 ϩ and CD8 ϩ T cells, especially efficiently after activation, and B cells. Among T cells, ELC similarly attracted both CD45RO ϩ memory and CD45RO -naive T cells. Consistently, CCR7 mRNA was selectively expressed in T and B cells and strongly up-regulated in T cells treated with interleukin 2 (IL-2) or with phytohemagglutinin (PHA) plus IL-2. By using in situ hybridization, we have further demonstrated similar localization of ELC and CCR7 mRNA in human lymphoid tissues. Collectively, ELC and CCR7 may be involved in homeostatic as well as immunoreactive trafficking of a broad spectrum of lymphocytes, especially activated T cells, into various lymphoid tissues.
Methods
Chemokines and mAb Production and purification of recombinant ELC-flag, TARC, LARC and eotaxin were described previously (6) (7) (8) 19) . MIP-1α, MIP-1β, MCP-1, MCP-2, MCP-3, RANTES and IL-8 were purchased from Peprotech (Rocky Hill, NJ). R-Phycoerythrin (PE)-anti-CD8 (DK25), PE-anti-CD3 (UCHT1), PE-anti-CD19 (HD37) and FITC-anti-CD45RO (UCHL1) were purchased from Dako Japan (Kyoto, Japan). FITC-anti-CD4 (Leu-3a), FITC-anti-CD14 (Leu-M3) and FITC-anti-CD16 (Leu-11a) were purchased from Becton Dickinson (Mount View, CA).
Cells
A human ECV304 endothelial cell line was obtained from the ATCC (Rockville, MA) and maintained in Medium 199 supplemented with 10% FCS. Peripheral blood leukocytes were fractionated according to surface markers as described previously (10) . In brief, peripheral blood mononuclear cells (PBMC) were isolated from EDTA-treated venous blood obtained from healthy adult donors by using Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden). Granulocytes were isolated from the pellet of Ficoll-Paque gradient by dextran sedimentation and hypotonic lysis of residual erythrocytes. After staining of PBMC with FITC-labeled anti-CD14, monocytes were positively and lymphocytes were negatively selected by using MACS (Milteny Biotec, Bergisch, Germany). B cells were stained with FITC-labeled anti-CD19 and positively selected by MACS. T cells were stained with FITClabeled anti-CD3 and positively selected by MACS. NK cells were sorted on a FACStar Plus (Becton Dickinson, Mountain View, CA) as CD3 -CD16 ϩ cells with appropriate forward and side scatter profiles. Purification of CD4 ϩ T cells and CD8 ϩ T cells was carried out by negative selection using Dynabeads (Dynal, Oslo, Norway) after incubation of PBMC with anti-CD16, anti-CD14, anti-CD20 and anti-CD8 or anti-CD4 respectively. The purity of each cell population was in the range of 95-98% as determined by flow cytometric analysis or staining with Diff-Quik (Baxter Scientific Products, McGaw Park, IL). In some experiments, lymphocytes were cultured with 200 units/ml of IL-2 (Shionogi, Osaka, Japan). In some experiments, T cells were expanded from PBMC by PHA (Life Technologies, Gaithersburg, MD) plus IL-2 (200 units/ml). In some experiments, purified T cells were cultured with IL-2 or with PHA plus IL-2 for sequential samplings.
Chemotaxis assays Migration of cells was assessed in a 48-well chemotaxis chamber (Neuroprobe, Cabin John, MD) essentially as described previously (6) . In brief, PBMC and lymphocytes were suspended at 2ϫ10 6 /ml in RPMI 1640 supplemented with 1% BSA and 20 mM HEPES, pH 7.4. Granulocytes were suspended at 2ϫ10 6 /ml in HBSS containing 10% BSA. For monocytes, polyvinylpyrolidone-treated filters with 5 µm pores were used; for neutrophils, polyvinylpyrolidone-free filters with 3 µm pores were used; for lymphocytes, polyvinylpyrolidonefree filters with 5 µm pores with surface facing the lower wells precoated with 5 µg/ml of fibronectin were used. Assays were carried out at 37°C for 1 h for neutrophils, 90 min for monocytes and 4 h for lymphocytes. Filters were washed, fixed and stained with Diff-Quick. The number of migrated cells in five randomly selected high-power (ϫ400) fields was counted. All assays were done in triplicate.
Transendothelial migration assay was carried out using a Transwell (6.5 mm diameter) with 5.0 µm pores (Costar, Cambridge, MA) essentially as described previously (20, 21) . In brief, ECV304 cells (2ϫ10 5 /100 µl) were placed in each insert and cultured at 37°C for 48-72 h. Before assay, endothelial monolayers were washed twice with assay medium (1:1 mixture of RPMI 1640 and Medium 199 supplemented with 0.5% BSA and 20 mM HEPES, pH 7.4). PBMC or cultured lymphocytes were suspended in the assay medium at 1ϫ10 7 /ml. The lower compartments contained 600 µl of the assay medium with or without a chemokine, while the upper compartments contained 100 µl of cell suspension. Assays were carried out at 37°C for 4 h in 5% CO 2 . Cells in 100 µl from the lower compartments were stained with labeled antibodies for 1 h on ice. Relative cell counts were determined for 60 s under a constant sheath pressure with appropriate gates based on forward and side scatter profiles.
Calcium mobilization assay
This was carried out as described previously (13) . In brief, cells were suspended at 3ϫ10 6 /ml in HBSS containing 1 mg/ml of BSA and 10 mM HEPES, pH 7.4, and incubated at 37°C in the dark with 1 µM Fura-PE3-AM (Texas Fluorescence Laboratories, Austin, TX). Cells were washed 3 times and resuspended at 1.25ϫ10 6 /ml in the same buffer. Then 2 ml of cell suspension was placed in a cuvette, and emission at 510 nm was measured upon excitation at 340 and 380 nm with 5 points/s on a luminescence spectrometer LS50B (Perkin-Elmer, Norwalk, CT) with constant stirring. After each measurement, emission with and without excess calcium was measured by sequential addition of 20 µl of 10% Triton X-100 and 200 µl of 0.5 M EGTA. Data were expressed by the ratio of emission at 510 nm by excitation at 340 and 380 nm (R340/380).
Ligand-binding assay
This was carried out essentially as described previously (8) . In brief, 2ϫ10 5 cells in 200 µl of RPMI 1640 containing 1% BSA, 20 mM HEPES, pH 7.4 and 0.02% sodium azide were incubated at 16°C for 1 h with 1 nM of ELC-SEAP without or with increasing concentrations of unlabeled chemokines. After washing 5 times, cells were lysed in 50 µl of 10 mM Tris-HCl, pH 8.0 and 1% Triton X-100. Samples were heated at 65°C for 10 min to inactivate cellular phosphatase and centrifuged to remove cell debris. AP activity in each lysate (10 µl) was determined by a chemiluminescence assay. All samples were determined in duplicate.
Northern blot analysis
This was carried out as described previously (10) . In brief, total RNA samples were prepared from various leukocyte populations by using Trizol reagent (Life Technologies). RNA samples (5 µg/lane) were fractionated by electrophoresis on a 1% agarose gel containing 0.66 M formaldehyde. Gels were blotted onto filter membranes (Hybond N ϩ ) (Amersham Japan, Tokyo). Multiple-tissue Northern blot and Immune blot filters were purchased from Clontech (Palo Alto, CA). Hybridization was carried out with the CCR7 cDNA (8) labeled with 32 P using Prime It II kit (Stratagene, La Jolla, CA) at 65°C in QuikHyb solution (Stratagene). After washing at 55°C with 0.2ϫSSC and 0.1% SDS, filters were exposed to X-ray films at -80°C with an intensifying screen. Some filters were rehybridized with the β-actin probe provided by Clontech.
In situ hybridization
This was carried out essentially as described previously (22) . In brief, cryosections (10 µm) of a lymph node and an appendix were fixed in 5% formaldehyde in 0.1 M phosphate buffer, pH 7.0, and pretreated with 10 µg/ml of proteinase K (Boehringer-Mannheim, Mannheim, Germany) for 5 min and 0.1 M triethanolamine/0.25% acetic acid anhydride for 10 min. Sections were hybridized overnight with sense and antisense 35 S-labeled RNA probes generated by an in vitro transcription system (Promega, Madison, WI). Sections were treated with 1 µg/ml of RNase A (Boehringer Mannheim) before high stringent wash. After dehydration, slides were dipped in the NBT-2 emulsion (Eastman Kodak, New Haven, CT) and exposed at 4°C in the dark for 14 days.
Results

ELC is chemotactic for lymphocytes
The recombinant ELC protein tagged with the Flag sequence (ELC-flag) was produced from 293/EBNA-1 cells and purified by using anti-Flag affinity chromatography and reverse-phase HPLC as described previously (8) . To examine chemotactic response of PBL to ELC, we first carried out a standard bare filter chemotaxis assay using a 48-well micro-chemotaxis chamber. As shown in Fig. 1 , monocytes or neutrophils did not respond to ELC-flag at all, whereas the same types of cells migrated vigorously toward MCP-1 or IL-8, the respective positive controls. Fresh lymphocytes showed little significant migration toward ELC-flag, either. However, after cultivation for 6 days with 200 U/ml of IL-2, lymphocytes vigorously migrated toward ELC-flag with a bell-shaped dose-response curve and a maximal migration at 300 ng/ml (~30 nM). Previously, the chemotactic response of 293/EBNA-1 cells stably expressing CCR7 to ELC-flag also exhibited a bellshaped dose-response curve with a maximal migration at 300 ng/ml (8) . A checkerboard-type analysis revealed that the migration of IL-2-stimulated lymphocytes toward ELC-flag was chemotactic rather than chemokinetic (data not shown).
Transendothelial migration of lymphocytes toward ELC
To determine classes and subsets of lymphocytes migrating toward ELC and also to prove effectiveness of ELC across an endothelial cell monolayer, we next carried out the transendothelial migration assay (20, 21) . The advantages of this assay are the similarity to conditions where chemokines act in vivo, the minimal handling of cells before the assay and a high signal-to-noise ratio, giving a much higher sensitivity than a conventional bare filter chemotaxis assay (20, 21) . As shown in Fig. 2 , we detected significant migration of even fresh lymphocytes toward ELC-flag in this assay primarily because of low levels of background migration. Both CD4 ϩ and CD8 ϩ T cells as well as CD19 ϩ B cells were attracted by ELC-flag. Furthermore, both CD4 ϩ and CD8 ϩ T cells expanded by PHA stimulation and IL-2 vigorously migrated toward ELC-flag. On the other hand, NK cells showed no significant migration toward ELC-flag. Monocytes did not respond to ELC-flag either while migrating vigorously toward MCP-1 and RANTES. When fresh T cells migrated toward ELC-flag were examined for the expression of CD45RO (Fig. 3) , both CD45RO -naive and CD45RO ϩ memory subsets were found to be similarly attracted by ELC-flag. In contrast, MCP-1 and RANTES preferentially attracted CD45RO ϩ memory T cells as reported previously (20, 21) . Thus, ELC was uniquely capable of attracting a broad spectrum of lymphocytes. Especially notable was the highly Fig. 1 . Chemotactic activity of ELC on PBL in a bare filter chemotaxis assay. Monocytes, neutrophils, lymphocytes and lymphocytes cultured for 6 days with IL-2 at 200 units/ml (ϩIL-2) were examined for chemotactic response to ELC-flag (closed circles) in a bare filter chemotaxis assay using a 48-well chemotaxis chamber. For positive controls, MCP-1 and IL-8 were used for monocytes and neutrophils respectively (closed squares). The number of migrating cells in five high-power (ϫ400) fields (HPF) was counted for each well. The assay was done in triplicate and mean Ϯ SE was obtained. Representative results from three separate experiments are shown. 
Calcium mobilization in T cells by ELC
Previously, we showed that ELC-flag induced vigorous calcium mobilization in K562 cells stably expressing CCR7 with an ED 50 of 0.9 nM (8). We, therefore, examined induction of calcium mobilization in normal lymphocytes by ELC-flag. For this, peripheral blood T cells were expanded by PHAstimulation plus IL-2 and then loaded with Fura-PE3-AM. As shown in Fig. 4 , ELC-flag induced a vigorous calcium mobilization in cultured activated T cells (Fig. 4A) with an ED 50 of 3 nM (Fig. 4B ).
Specific binding of ELC-SEAP to lymphocytes
Previously, we demonstrated specific binding of ELC to CCR7 by using ELC protein fused with the secreted form of alkaline phosphatase (ELC-SEAP) (8) . Furthermore, we demonstrated that among 10 CC chemokines tested, only ELC-flag displaced the binding of 1 nM ELC-SEAP to K562 cells stably expressing CCR7 with an IC 50 of 18 nM (8). We, therefore, examined specific binding of ELC-SEAP to PBL. As shown in Fig. 5(A) , the specific binding of ELC-flag to PBL was completely blocked by excess ELC-flag but not by nine other CC chemokines. We further compared the binding of ELC-SEAP to PBL, PBL cultured with IL-2 and T cells expanded by PHA stimulation plus IL-2. As shown in Fig. 5(B) , the binding of ELC-SEAP to these three types of cells was dose dependently displaced by ELC-flag with an IC 50 of 1.6-5.7 nM. Thus, ELC bound to fresh PBL, PBL cultured with IL-2 and T cells expanded with PHA plus IL-2 with affinity and specificity very similar to those for CCR7 (8) . Furthermore, PBL cultured with IL-2 as well as T cells expanded with PHA plus IL-2 consistently showed specific binding of ELC-SEAP at levels much higher than those of fresh PBL.
Expression of CCR7 mRNA in lymphocytes Previously, EBI1/CCR7 mRNA was shown to be expressed in certain lymphoblastoid cell lines and PBMC (14, 18) . However, its expression in specific leukocyte types has not been vigorously examined. As shown in Fig. 6(A) , T cells of both CD4 ϩ and CD8 ϩ lineages as well as B cells were positive for CCR7 mRNA. On the other hand, NK cells, monocytes and granulocytes were negative. Furthermore, as shown in Fig. 6(B) , the expression of CCR7 mRNA in T cells was rapidly and strongly up-regulated by stimulation with IL-2 or with PHA plus IL-2. Collectively, specific expression of CCR7 mRNA in T and B cells as well as strong up-regulation of CCR7 mRNA in stimulated T cells correlated well with their responses to ELC in the chemotaxis, calcium mobilization and specific binding assays described above.
Expression of ELC and CCR7 mRNA in tissues Previously, CCR7/EBI1 mRNA was shown to be expressed in some lymphoid tissues such as spleen and lymph nodes (14, 18) . We re-examined tissue distribution of CCR7 mRNA by using filters with RNA from a wide variety of tissues. As shown in Fig. 6(C) , CCR7 mRNA was strongly expressed in PBL and various lymphoid tissues such as spleen, thymus, lymph nodes and appendix. Weak expression was also detected in small intestine, colon, placenta, bone marrow, and fetal liver. Control hybridization with the β-actin probe confirmed similar loading of RNA samples. Thus, the selective expression of CCR7 mRNA in various lymphoid tissues is very similar to that of ELC mRNA (8) .
Since ELC and CCR7 mRNA are expressed in similar lymphoid tissues, we further examined localization of ELC and CCR7 mRNA by using in situ hybridization. In a lymph node (Fig. 7A) , ELC mRNA was strongly expressed in the cortex, especially in the inner cortex. Signals were less intense in the parafollicular regions and germinal centers. Similarly, CCR7 mRNA was present in the inner cortex and to a lesser extent in the outer cortex and germinal centers. In the case of an appendix (Fig. 7B) , ELC mRNA was strongly expressed in the parafollicular regions but not in the germinal centers of the secondary lymphoid nodules. Similarly, CCR7 mRNA was strongly expressed in the parafollicular regions and less intensely in the outer regions of the germinal centers. Essentially no signals were observed by sense probes (not shown).
Discussion
In the present study, we have examined the chemotactic activity of a recently identified CC chemokine ELC (8), also termed MIP-3β (17), on PBL. In a bare filter assay, ELC attracted only IL-2-stimulated lymphocytes (Fig. 1) . By a sensitive transendothelial migration assay, however, ELC was shown to attract resting T cells of both CD4 ϩ and CD8 ϩ lineages as well as B cells (Fig. 2) . Furthermore, T cells activated by PHA stimulation plus IL-2 vigorously migrated toward ELC (Fig. 2) . Among resting T cells, ELC attracted both naive (CD45RO -) and memory (CD45RO ϩ ) subsets (Fig. 3) . ELC also induced rapid calcium mobilization in T cells expanded by PHA stimulation plus IL-2 (Fig. 4) . Thus, ELC is chemotactic for a broad spectrum of lymphocytes and especially T cells activated by IL-2 or PHA plus IL-2. Consistently, CCR7, the known specific receptor for ELC (8) , is expressed selectively in freshly isolated CD4 ϩ and CD8 ϩ T cells as well as B cells, but not in NK cells, monocytes or neutrophils, and strongly up-regulated in T cells stimulated with IL-2 or PHA plus IL-2 (Fig. 6) .
The binding of ELC-SEAP to lymphocytes is specifically blocked by ELC but not by nine other CC chemokines tested in parallel (Fig. 5) . Thus, in contrast to the traditional rule that the chemokine receptors tend to be shared by multiple ligands (1-3) , the lymphocyte receptor for ELC is quite specific for ELC. This also fits well to the nature of CCR7 which is highly specific for ELC (8) . Notably, lymphocytes cultured with IL-2 or T cells expanded by PHA stimulation plus IL-2 bound ELC-SEAP at levels much higher than fresh lymphocytes (Fig. 5) . Consistently, the CCR7 mRNA was found to be strongly upregulated in T cells stimulated with IL-2 or PHA plus IL-2 (Fig. 6) . Previously, mRNA expression of CCR1, CCR2 or CCR6 in T cells was shown to be up-regulated by IL-2 alone but not by PHA plus IL-2 (11, 23) . Furthermore, it was shown that surface expression of CXCR4 in T cells was rapidly upregulated by stimulation with PHA or IL-2, while that of CCR5 showed only a gradual increase over 12 days of culture with IL-2 but not with PHA (24) . Thus, the expression of each chemokine receptor in T cells appears to be differentially regulated by IL-2 and by antigenic stimulation.
The ability of ELC to attract both CD45RO -naive and CD45RO ϩ memory T cells is also unique among known chemokines. For example, RANTES, MIP-1α, MIP-1β, MCP-1, MCP-2 and MCP-3 were all shown to preferentially attract the memory type CD45RO ϩ T cells (Fig. 3) (20, 25) . MCP-2 was the only CC chemokine that was shown to attract the naive-type (CD45RA ϩ ) T cells to some extent (25) . Recently, we reported a novel human CC chemokine PARC (pulmonary and activation-regulated chemokine) that is also specifically chemotactic for lymphocytes and expressed selectively in the lung besides some other lymphoid tissues (12) . By in situ hybridization, lung alveolar macrophages and follicular dendritic cells in germinal centers of lymph nodes were strongly positive for PARC mRNA (12) . Interestingly, the same chemokine, termed DC-CK1, was reported to attract selectively the naive CD45RA ϩ subsets of CD4 ϩ and CD8 ϩ T cells (26) . Furthermore, it was shown that a mAb to CXCR4 predominantly stained CD26 low CD45RA ϩ CD45RO -naive/unactivated T cells, while a mAb to CCR5 predominantly stained CD26 high CD45RA low CD45RO ϩ activated/memory T cells (24) . Obviously, chemokines acting on T cells tend to be individually directed to particular functional subsets. The net expression pattern of shared and/or specific receptors for each chemokine on various T cell subsets is likely to determine their selectivity.
Another unique feature of ELC is that it is chemotactic for B cells (Fig. 2) . Consistently, B cells express CCR7 mRNA (Fig. 6) . Previously, Schall et al. reported that MIP-1α preferentially attracted B cells and CD8 ϩ T cells at low concentrations (~100 pg/ml) and CD4 ϩ T cells at high concentrations (~10 ng/ml) in a bare filter chemotaxis assay (27) . However, Roth et al. reported that none of the six CC chemokines, MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β, and two CXC chemokines, IL-8 and IP-10, induced significant transendothelial migration in B cells (25) . Recently, a novel murine CC chemokine MCP-5, whose human counterpart remains to be identified, was shown to attract B cells to some extent, even though it was primarily directed to eosinophils and monocytes (28) . A CXC chemokine SDF-1/PBSF was shown to be a highly efficient chemoattractant for lymphocytes (29) , and its receptor, CXCR4, was shown to be expressed on B cells, T cells, and monocytes (24) . Thus, SDF-1/PBSF may also be chemotactic for B cells. At any rate, the ability of ELC to induce transendothelial migration of B cells may be important in tissue recruitment of B cells.
Both ELC and CCR7 are expressed in various lymphoid tissues (Fig. 6) (8,18) . In the present study, we examined the tissue localization of ELC and CCR7 mRNA by using in situ hybridization (Fig. 7) . ELC mRNA is strongly expressed in the parafollicular and inner cortex regions of a lymph node and in the parafollicular regions of an appendix. Likewise, CCR7 mRNA is strongly expressed in the parafollicular and inner cortex regions and to a lesser extent in the outer cortex and germinal centers of a lymph node, and in the parafollicular area and to a lesser extent in the marginal areas of germinal centers in an appendix. Thus, the cells expressing ELC are mainly localized in the so-called T cell zones of the lymphoid tissues. The T cell zone is characterized by the presence of high endothelial venules (HEV) and interdigitating dendritic cells, and is richly populated by recirculating lymphocytes (30, 31) . The cells expressing CCR7 are also mostly colocalized in the T cell zones of lymphoid tissues and also in the germinal centers to some extent. Since recirculating lymphocytes are known to enter into lymph nodes through HEV in the T cell zone (30) and ELC has a chemotactic activity through a monolayer of endothelial cells (Fig. 2) , ELC produced in the T cell zone may attract T cells and B cells expressing CCR7 into the T cell zone. On the other hand, ELC is little expressed in the germinal centers where B cell differentiation and antibody production take place (32) . Thus, ELC may not be a chemokine directing B cells into the follicles. B cells may migrate into follicles by guidance of other chemokines such as the unknown ligand of BLR1 (33) . Furthermore, PARC/DC-CK1 was shown to be expressed in follicular dendritic cells of germinal centers (12, 26) , whereas RANTES in T cells and HEV of cortical parafollicular areas (34) . Recently, we have found that another CC chemokine SLC is also a functional ligand for CCR7 (35) and expressed mainly in the T cell zones of secondary lymphoid tissues (36) . Furthermore, Gunn et al. have reported that murine SLC is expressed in HEV of lymph nodes and Peyer's patches, and induces firm adhesion of naive T cells onto ICAM-1 via β 2 integrin, a necessary step for lymphocyte recruitment (37) . Thus, it is obvious that multiple chemokines are coordinately and sequentially involved in migration and homing of particular subsets of lymphocytes into particular lymphoid tissue microenvironments.
Although the area positive for ELC mRNA is the T cell zone, T cells are not likely to express ELC, since we have never detected ELC mRNA in fresh lymphocytes or normal T cells cultured in the presence of IL-2 and/or PHA (unpublished results). The expression of MIP-3β, identical to ELC, was shown to be induced in monocytes upon stimulation with lipopolysaccharide, especially in the presence of anti-IL-10 (17). Thus, the cells expressing ELC may be HEV or dendritic cells present in the T cell zone of lymphoid tissues. The exact identity of the cells expressing ELC in human and murine lymphoid tissues is now under investigation.
In summary, ELC is likely to be an important regulator in homeostatic as well as immunoreactive trafficking of CCR7-expressing T and B cells into and within various lymphoid tissues. Thus, elucidation of its physiologic role and pathological significance may give us a new method to control immune responses. Furthermore, CCR7/EBI1 has been shown to be expressed in B cells infected by EBV (14, 15) and in T cells infected by HHV6 or HHV7 (16) . Considering the strong constitutive expression of ELC and also of SLC, another functional ligand CCR7 (35) , in various lymphoid tissues, lymphocytes infected with these lymphotropic herpes viruses may be attracted into various lymphoid tissues by these chemokines. This may be one of the mechanisms for in vivo persistence of lymphoid cells infected with these lymphotropic herpes viruses.
